APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Selected research

Market Analysis & Forecast

Global Cell Therapy Market Analysis and Forecast 2026-2032

31 December 2025195 pages

Choose your research edition.

Industry ResearchCell Therapy Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.

Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.

Read the full market overview

North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.

Report Includes

This report presents an overview of global market for Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Cell Therapy Segment by Company

Gilead Sciences

Novartis

Osiris

Vericel Corporation

Vcanbio

Fujifilm Cellular Dynamics

JCR Pharmaceuticals

Beike Biotechnology

Golden Meditech

Guanhao Biotech

Cell Therapy Segment by Type

Stem Cell

Non-Stem Cell

Cell Therapy Segment by Application

Hospital

Clinic

Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stem Cell Major Player Table 3. Non-Stem Cell Major Player Table 4. Global Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Cell Therapy Industry Trends Table 8. Cell Therapy Industry Drivers Table 9. Cell Therapy Industry Opportunities and Challenges Table 10. Cell Therapy Industry Restraints Table 11. Global Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Cell Therapy Market Share by Region (2021-2026) Table 14. Global Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Cell Therapy Market Share by Region (2027-2032) Table 16. Global Cell Therapy Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Cell Therapy Revenue Market Share by Players (2021-2026) Table 18. Global Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cell Therapy Key Players Headquarters & Area Served Table 20. Global Cell Therapy Players, Product Type & Application Table 21. Global Cell Therapy Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Cell Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Cell Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Cell Therapy Revenue Market Share by Type (2021-2026) Table 28. Global Cell Therapy Revenue Market Share by Type (2027-2032) Table 29. Global Cell Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Cell Therapy Revenue Market Share by Application (2021-2026) Table 33. Global Cell Therapy Revenue Market Share by Application (2027-2032) Table 34. Gilead Sciences Company Information Table 35. Gilead Sciences Business Overview Table 36. Gilead Sciences Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Gilead Sciences Cell Therapy Product Portfolio Table 38. Gilead Sciences Recent Development Table 39. Novartis Company Information Table 40. Novartis Business Overview Table 41. Novartis Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novartis Cell Therapy Product Portfolio Table 43. Novartis Recent Development Table 44. Osiris Company Information Table 45. Osiris Business Overview Table 46. Osiris Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Osiris Cell Therapy Product Portfolio Table 48. Osiris Recent Development Table 49. Vericel Corporation Company Information Table 50. Vericel Corporation Business Overview Table 51. Vericel Corporation Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Vericel Corporation Cell Therapy Product Portfolio Table 53. Vericel Corporation Recent Development Table 54. Vcanbio Company Information Table 55. Vcanbio Business Overview Table 56. Vcanbio Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Vcanbio Cell Therapy Product Portfolio Table 58. Vcanbio Recent Development Table 59. Fujifilm Cellular Dynamics Company Information Table 60. Fujifilm Cellular Dynamics Business Overview Table 61. Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Fujifilm Cellular Dynamics Cell Therapy Product Portfolio Table 63. Fujifilm Cellular Dynamics Recent Development Table 64. JCR Pharmaceuticals Company Information Table 65. JCR Pharmaceuticals Business Overview Table 66. JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. JCR Pharmaceuticals Cell Therapy Product Portfolio Table 68. JCR Pharmaceuticals Recent Development Table 69. Beike Biotechnology Company Information Table 70. Beike Biotechnology Business Overview Table 71. Beike Biotechnology Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Beike Biotechnology Cell Therapy Product Portfolio Table 73. Beike Biotechnology Recent Development Table 74. Golden Meditech Company Information Table 75. Golden Meditech Business Overview Table 76. Golden Meditech Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Golden Meditech Cell Therapy Product Portfolio Table 78. Golden Meditech Recent Development Table 79. Guanhao Biotech Company Information Table 80. Guanhao Biotech Business Overview Table 81. Guanhao Biotech Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Guanhao Biotech Cell Therapy Product Portfolio Table 83. Guanhao Biotech Recent Development Table 84. North America Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 90. North America Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 98. China Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 99. China Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 100. China Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 101. China Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Cell Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Cell Therapy Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia Cell Therapy Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Cell Therapy Image Figure 2. Global Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stem Cell Image Figure 5. Non-Stem Cell Image Figure 6. Global Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Cell Therapy Market Size (US$ Million) & (2021-2032) Figure 11. Global Cell Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cell Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Cell Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cell Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cell Therapy Revenue Market Share by Type (2021-2032) Figure 18. Global Cell Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cell Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Cell Therapy Revenue Market Share by Application (2021-2032) Figure 21. North America Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Cell Therapy Revenue Share by Type (2021-2032) Figure 23. North America Cell Therapy Revenue Share by Application (2021-2032) Figure 24. North America Cell Therapy Revenue Share by Country (2021-2032) Figure 25. United States Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Cell Therapy Revenue Share by Type (2021-2032) Figure 30. Europe Cell Therapy Revenue Share by Application (2021-2032) Figure 31. Europe Cell Therapy Revenue Share by Country (2021-2032) Figure 32. Germany Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Cell Therapy Revenue Share by Type (2021-2032) Figure 42. China Cell Therapy Revenue Share by Application (2021-2032) Figure 43. Asia Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Cell Therapy Revenue Share by Type (2021-2032) Figure 45. Asia Cell Therapy Revenue Share by Application (2021-2032) Figure 46. Asia Cell Therapy Revenue Share by Region (2021-2032) Figure 47. Japan Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Cell Therapy Revenue Share by Type (2021-2032) Figure 55. SAMEA Cell Therapy Revenue Share by Application (2021-2032) Figure 56. SAMEA Cell Therapy Revenue Share by Country (2021-2032) Figure 57. Brazil Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell
  • Non-Stem Cell
Applications
  • Hospital
  • Clinic
Companies covered
  • Gilead Sciences
  • Novartis
  • Osiris
  • Vericel Corporation
  • Vcanbio
  • Fujifilm Cellular Dynamics
  • JCR Pharmaceuticals
  • Beike Biotechnology
  • Golden Meditech
  • Guanhao Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell Therapy Market by Type
  3. 1.2.1 Global Cell Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cell
  5. 1.2.3 Non-Stem Cell
  6. 1.3 Cell Therapy Market by Application
  7. 1.3.1 Global Cell Therapy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Cell Therapy Market Dynamics
  1. 2.1 Cell Therapy Industry Trends
  2. 2.2 Cell Therapy Industry Drivers
  3. 2.3 Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Cell Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell Therapy Market Perspective (2021-2032)
  2. 3.2 Global Cell Therapy Growth Trends by Region
  3. 3.2.1 Global Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell Therapy Revenue by Players
  2. 4.1.1 Global Cell Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Cell Therapy Players, Product Type & Application
  8. 4.5 Global Cell Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell Therapy Market CR5 and HHI
  11. 4.6.3 2025 Cell Therapy Tier 1, Tier 2, and Tier 3
5 Cell Therapy Market Size by Type
  1. 5.1 Global Cell Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Cell Therapy Revenue Market Share by Type (2021-2032)
6 Cell Therapy Market Size by Application
  1. 6.1 Global Cell Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Cell Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Gilead Sciences
  2. 7.1.1 Gilead Sciences Company Information
  3. 7.1.2 Gilead Sciences Business Overview
  4. 7.1.3 Gilead Sciences Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Gilead Sciences Cell Therapy Product Portfolio
  6. 7.1.5 Gilead Sciences Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Cell Therapy Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Osiris
  14. 7.3.1 Osiris Company Information
  15. 7.3.2 Osiris Business Overview
  16. 7.3.3 Osiris Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Osiris Cell Therapy Product Portfolio
  18. 7.3.5 Osiris Recent Developments
  19. 7.4 Vericel Corporation
  20. 7.4.1 Vericel Corporation Company Information
  21. 7.4.2 Vericel Corporation Business Overview
  22. 7.4.3 Vericel Corporation Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Vericel Corporation Cell Therapy Product Portfolio
  24. 7.4.5 Vericel Corporation Recent Developments
  25. 7.5 Vcanbio
  26. 7.5.1 Vcanbio Company Information
  27. 7.5.2 Vcanbio Business Overview
  28. 7.5.3 Vcanbio Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Vcanbio Cell Therapy Product Portfolio
  30. 7.5.5 Vcanbio Recent Developments
  31. 7.6 Fujifilm Cellular Dynamics
  32. 7.6.1 Fujifilm Cellular Dynamics Company Information
  33. 7.6.2 Fujifilm Cellular Dynamics Business Overview
  34. 7.6.3 Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
  36. 7.6.5 Fujifilm Cellular Dynamics Recent Developments
  37. 7.7 JCR Pharmaceuticals
  38. 7.7.1 JCR Pharmaceuticals Company Information
  39. 7.7.2 JCR Pharmaceuticals Business Overview
  40. 7.7.3 JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 JCR Pharmaceuticals Cell Therapy Product Portfolio
  42. 7.7.5 JCR Pharmaceuticals Recent Developments
  43. 7.8 Beike Biotechnology
  44. 7.8.1 Beike Biotechnology Company Information
  45. 7.8.2 Beike Biotechnology Business Overview
  46. 7.8.3 Beike Biotechnology Cell Therapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Beike Biotechnology Cell Therapy Product Portfolio
  48. 7.8.5 Beike Biotechnology Recent Developments
  49. 7.9 Golden Meditech
  50. 7.9.1 Golden Meditech Company Information
  51. 7.9.2 Golden Meditech Business Overview
  52. 7.9.3 Golden Meditech Cell Therapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Golden Meditech Cell Therapy Product Portfolio
  54. 7.9.5 Golden Meditech Recent Developments
  55. 7.10 Guanhao Biotech
  56. 7.10.1 Guanhao Biotech Company Information
  57. 7.10.2 Guanhao Biotech Business Overview
  58. 7.10.3 Guanhao Biotech Cell Therapy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Guanhao Biotech Cell Therapy Product Portfolio
  60. 7.10.5 Guanhao Biotech Recent Developments
8 North America
  1. 8.1 North America Cell Therapy Revenue (2021-2032)
  2. 8.2 North America Cell Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Cell Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Cell Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell Therapy Revenue by Country
  11. 8.6.1 North America Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell Therapy Revenue (2021-2032)
  2. 9.2 Europe Cell Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Cell Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Cell Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell Therapy Revenue by Country
  11. 9.6.1 Europe Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell Therapy Revenue (2021-2032)
  2. 10.2 China Cell Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Cell Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Cell Therapy Revenue by Type (2027-2032)
  5. 10.3 China Cell Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Cell Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Cell Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Cell Therapy Revenue by Application (2027-2032)
  9. 10.5 China Cell Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell Therapy Revenue (2021-2032)
  2. 11.2 Asia Cell Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Cell Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Cell Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell Therapy Revenue by Country
  11. 11.6.1 Asia Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Cell Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell Therapy Revenue by Country
  11. 12.6.1 SAMEA Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst